SecBot SecBot

MOBI

Mobia Medical, Inc.
Nasdaq· CIK 0001489993
$11.14 +0.41 (+3.82%)
Oct 27 4:00 PM ET · prev $10.73
Market cap
$346.6M
Small cap
Consensus
Buy
90% Buy or better · 10 analysts
Median target
$18.00
+62% · range $16.00–19.00
Next earnings
Nov 5
in 9 days · EPS est. −$0.48
Since first trade
−5.2%
from $11.75 · May 8
30 days
+26.2%
from $8.83
Range since listing
$8.09–14.63
−24% from high · low Oct 16
Avg volume 20D
150.5K
shares / day
Short interest
850.2K
≈2.5% of shares · −21.6%
Days to cover
6.5
at average volume
Insider net
+$9.2M
6 buyers · 0 sellers · since May 11
New fund stakes
1
Q2 2026 13F · 0 exits
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 1 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 2/4 ·Next Earnings date, Nov 5, 2026
Strongest BULLISH Director Casey Tansey made a single open-market purchase of 35,572 shares of Mobia Medical (MOBI) for $409K…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    6 insiders bought $9.2M at an average $14.53. No open-market sales. Price is 23% below their cost.

  • InstitutionsMIXED

    Q2 2026: 1 added (1 new), 0 trimmed or exited. Largest new: Farallon Capital Management, L.L.C $15.1M.

  • AnalystsBULLISH

    9 of 10 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.440 → −$0.484 over 90 days. 0 up, 4 down in 30 days.

  • Short sellersCOVERING

    Short interest −21.6% to 850.2K shares. 6.5 days to cover, ≈2.5% of shares.

  • TrendRANGE

    11% above its 50-day average.

Who's buying

13F· Q2 2026
1
new positions
0
exits
$15.1M
in new stakes
FundMoveSharesValue
FARALLON CAPITAL MANAGEMENT, L.L.C.NEW1,128,557$15.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 90% rate it Buy or better
Strong Buy5Buy4Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +62%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 20, 2026BTIG
REITERATE
REITERATEBuy
Aug 12, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Aug 12, 2026BTIG
REITERATE
REITERATEBuy
Jun 2, 2026JP Morgan
INITIATE
INITIATEOverweight
Jun 2, 2026B of A Securities
INITIATE
INITIATEBuy
Jun 2, 2026BTIG
INITIATE
INITIATEBuy

Washington

Corporate Lobbying

7 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$9.2M
bought · 6 insiders
$0
sold · 0 insiders
−23.3%
vs their $14.53 cost
DateInsiderTypeValue
Sep 11, 2026
Leavitt Chase C.
SEE REMARKS
BUY$20.6K
Sep 2, 2026
Rawat Prashant B.
Chief Operating Officer
EXERCISE$50.7K
Aug 18, 2026
Tansey Casey M
Director
BUY$198.5K
Aug 17, 2026
Tansey Casey M
Director
BUY$203.4K
Aug 14, 2026
Tansey Casey M
Director
BUY$1.3K
Aug 14, 2026
Tansey Casey M
Director
BUY$183.1K
Aug 13, 2026
Tansey Casey M
Director
BUY$409.3K
Jul 30, 2026
Curet Myriam
Director
AWARD19,740 sh

Earnings setup

Estimates
Nov 5
reports in 9 days
−$0.48
EPS estimate, this quarter
−10%
estimate change, 90 days
0↑ 4↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.48-$0.55–-$0.46+0.0%$14.0M
Next Q-$0.55-$0.56–-$0.54+0.0%$15.3M
Current FY-$3.07-$3.45–-$2.20+0.0%$55.1M
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
850,177
shares short
-21.6%
vs prior settlement
6.5
days to cover
≈2.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 SEC
Mobia Medical filed two 8-K/A amendments on October 16, 2026, each supplementing prior Item 5.02 reports to disclose…
8-K/A — Impact 2/10
Oct 15, 2026 SEC
Mobia Medical Inc. announced it will report its Q3 2026 results on November 5, 2026.
PRESS-RELEASE — Impact 1/10
Oct 15, 2026 Earnings
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
AUSTIN, Texas, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical devic
Sep 11, 2026 Insider
Leavitt Chase C. bought 2,000 shares
SEE REMARKS @ $10.30 ($20.6K)
Sep 2, 2026 Insider
Rawat Prashant B. acquired via exercise 15,000 shares
Chief Operating Officer @ $3.38 ($50.7K)
Aug 20, 2026 SEC
Director Tansey Casey M made a series of open-market purchases totaling $996K over five trading days, the largest of…
INSIDER-BUY — Impact 5/10
Aug 18, 2026 Insider
Tansey Casey M bought 16,441 shares
Director @ $12.07 ($198.5K)
Jun 30, 2026 Inst.
FARALLON CAPITAL MANAGEMENT, L.L.C. — NEW
1,128,557 shares ($15.1M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
MOBI Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Oct 15, 2026
Earnings
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
AUSTIN, Texas, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for…
Sep 30, 2026
Short interest
Short Interest: MOBI up 131% to 1.1M shares
Settlement 2026-09-30 | Days to cover: 2.84 | ≈3.26% of shares outstanding (est.)
Aug 28, 2026
Press release
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
AUSTIN, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for…
Aug 11, 2026
Earnings date
MOBI Q2 2026 Earnings Scheduled — 2026-08-11
Jul 2, 2026
Press release
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke…

SecBot reports

11 filings · 4 bullish · 0 bearish · 7 neutral
All MOBI filing & press-release reports (11)